Skip to main content
SpringerLink
Log in

In silico modeling of pathogenic point mutations in PSEN1 as studied in South-east Asia

  • Research Article
  • Published:
Toxicology and Environmental Health Sciences Aims and scope Submit manuscript

Abstract

In Asia, particularly in Korea and Japan, there is an increase in the aging population, and a subsequent increase in the number of Alzheimer’s disease (AD) patients. Early onset AD (EOAD) represents a minority of all cases. Three genes are associated with EOAD: APP, PSEN1, and PSEN2. PSEN1 is the most common causative gene of EOAD. Recently, more than 200 pathogenic mutations associated with EOAD were discovered in the coding region of PSEN1. To verify the damaging properties of mutations in pre-senilins, cell studies such as COS-1, HEK-293 were performed. The disadvantages of transfection analyses are that they are expensive and time-consuming. In addition, these studies cannot be performed for all mutations. In silico analyses (e.g., Sorting Intolerant from Tolerant [SIFT], PolyPhen2) can be useful in predicting which mutations are involved in disease progression. In addition, 3-D modeling can be also help to estimate the role of mutations in AD onset. This work focuses on AD-causative point mutations in PSEN1 as studied in South-East Asian countries. Predictions were performed for PSEN1 with point mutations to estimate their pathogenic nature and potential role in disease progression. In this study, PolyPhen 2 and SIFT software predictions, as well as 3-D modeling, were performed for all mutations. Most of the mutations were confirmed as pathogenic mutations by these algorithms; however, in silico modeling cannot replace clinical, functional, segregation, and association studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Catindig, J. A., Venketasubramanian, N., Ikram, M. K. & Chen, C. Epidemiology of dementia in Asia: insights on prevalence. trends and novel risk factors. J. Neurol. Sci. 321, 11–16 (2012).

    Article  PubMed  Google Scholar 

  2. Bagyinszky, E., Youn, Y. C., An, S. S. & Kim, S. Y. The genetics of Alzheimer’s disease. Clin. Interv. Aging 9, 535–551 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Larner, A. J. & Doran, M. Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J. Neurol. 253, 139–158 (2006).

    Article  CAS  PubMed  Google Scholar 

  4. Guerreiro, R. J. et al. Genetic screening of Alzheimer’s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol. Aging 31, 725–731 (2010).

    Article  CAS  PubMed  Google Scholar 

  5. Murayama, O. et al. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer’s disease. Neurosci. Lett. 265, 61–63 (1999).

    Article  CAS  PubMed  Google Scholar 

  6. Kaneko, H. et al. Enhanced Accumulation of Phosphorylated a-Synuclein and Elevated β-Amyloid 42/40 Ratio Caused by Expression of the Presenilin-1 T440 Mutant Associated with Familial Lewy Body Disease and Variant Alzheimer’s Disease. J. Neurosci. 27, 13092–13097 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ng, P. C. & Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acid. Res. 31, 3812–3814 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hu, J. & Ng, P. C. SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins. PLo. One 8, e77940 (2013).

    Article  CAS  Google Scholar 

  10. Källberg, M. et al. Template-based protein structure modeling using the RaptorX web server. Natur. Protocols 7, 1511–1522 (2012).

    Article  Google Scholar 

  11. Ataka, S. et al. A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis. Arch. Neurol. 61, 1773–1776 (2004).

    Article  PubMed  Google Scholar 

  12. Kamino, K. et al. Three different mutations of presenilin 1 gene in early-onset Alzheimer’s disease families. Neurosci. Lett. 208, 195–198 (1996).

    Article  CAS  PubMed  Google Scholar 

  13. Jia, J., Xu, E., Shao, Y., Jia, J., Sun, Y. & Li, D. One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer’s disease. J. Alzheime. Dis. 7, 119–124 (2005).

    CAS  Google Scholar 

  14. Fang, B., Jia, L. & Jia, J. Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells. Neurosci. Lett. 406, 33–37 (2006).

    Article  CAS  PubMed  Google Scholar 

  15. Jiao, B. et al. Mutational analysis in early-onset familial Alzheimer’s disease in Mainland China. Neurobiol. Aging 35, 1957.e1–6 (2014).

    Article  PubMed  Google Scholar 

  16. La Bella, V. et al. A novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early-onset Alzheimer’s disease. Eur J Neurol 11, 521–524 (2004).

    Article  CAS  PubMed  Google Scholar 

  17. Raux, G. et al. Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update. J. Med. Genetics 42, 793–795 (2005).

    Article  CAS  Google Scholar 

  18. Romero, I. et al. A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer’s disease. Neuroreport 10, 2255–2260 (1999).

    Article  CAS  PubMed  Google Scholar 

  19. Yasuda, M. et al. A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2. Arch. Neurology 56, 65–69 (1999).

    Article  CAS  Google Scholar 

  20. Fang, B. Y. & Jia, J. P. The effect of two newly Chinese presenilin-1 mutations on the sensitivity to trophic factor withdrawal in human neuroblastoma cells. Zhonghua Yi Xue Z. Zhi 87, 336–340 (2007).

    CAS  Google Scholar 

  21. Kim, H. J., Kim, H. Y., Ki, C. S. & Kim, S. H. Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer’s disease: clinical characteristics and genetic identification. Neurol. Sci. 31, 781–783 (2010).

    Article  PubMed  Google Scholar 

  22. Cruts, M. et al. Molecular genetic analysis of familial early-onset Alzheimer’s disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4, 2363–2372 (1995).

    Article  CAS  PubMed  Google Scholar 

  23. Arai, N. et al. Familial cases presenting very early onset autosomal dominant Alzheimer’s disease with I143T in presenilin-1 gene: implication for genotype-phenotype correlation. Neurogenetics 9, 65–67, 2008.

    Article  PubMed  Google Scholar 

  24. Hattori, S. et al. A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer’s disease with spastic paraparesis. Neurosci. Lett. 368, 319–322 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. Hong, K. S. et al. Clinical and genetic analysis of a pedigree of a thirty-six-year-old familial Alzheimer’s disease patient. Biol. Psychiatry 42, 1172–1176 (1997).

    Article  CAS  PubMed  Google Scholar 

  26. Kim, J. et al. A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer’s disease: clinical, neuroimaging, and neuropathological findings. Neurosci. Lett. 530, 109–114 (2012).

    Article  CAS  PubMed  Google Scholar 

  27. Higuchi, S. et al. A novel PS1 Mutation (W165G) in a Japanese family with early-onset Alzheimer’s disease. Alzheimer’. Reports 3, 227–231 (2000).

    Google Scholar 

  28. Guo, J. et al. A novel presenilin 1 mutation (Ser169del) in a Chinese family with early-onset Alzheimer’s disease. Neurosci. Lett. 468, 34–37 (2010).

    Article  CAS  PubMed  Google Scholar 

  29. Kasuga, K. et al. Depression and psychiatric symptoms preceding onset of dementia in a family with early-onset Alzheimer disease with a novel PSEN1 mutation. J. Neurology 256, 1351–1353 (2009).

    Article  Google Scholar 

  30. Yasuda, M. et al. A novel missense mutation in the presenilin-1 gene in a familial Alzheimer’s disease pedigree with abundant amyloid angiopathy. Neurosci. Lett. 232, 29–32 (1997).

    Article  CAS  PubMed  Google Scholar 

  31. Janssen, J. C. et al. Early onset familial Alzheimer’s disease: Mutation frequency in 31 families. Neurology 60, 235–239 (2003).

    Article  CAS  PubMed  Google Scholar 

  32. Park, H. K. et al. Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer’s disease. J. Korean Med. Sci. 23, 213–217 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sugiyama, N. et al. A novel missense mutation (G209R) in exon 8 of the presenilin 1 gene in a Japanese family with presenile familial Alzheimer’s disease. Hum. Mutat. 14, 90 (1999).

    Article  CAS  PubMed  Google Scholar 

  34. Takao, M. et al. A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta. Neuropathol. 104, 155–170 (2002).

    Article  CAS  PubMed  Google Scholar 

  35. Zekanowski, C. et al. Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment. Exp. Neurol. 200, 82–88 (2006).

    Article  CAS  PubMed  Google Scholar 

  36. Jiang, H. Y. et al. Identification of PSEN1 mutations p.M233L and p.R352C in Han Chinese families with early-onset familial Alzheimer’s disease. Neurobiol. Aging 36, 1602.e3–6 (2015).

    Article  PubMed  Google Scholar 

  37. Sodeyama, N. et al. Very early onset Alzheimer’s disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237Ile). J. Neurology. Neurosurgery Psychiatry 71, 556–557 (2001).

    Article  CAS  Google Scholar 

  38. Jiao, B. et al. Mutational analysis in early-onset familial Alzheimer’s disease in Mainland China. Neurobiol. Aging 35, 1957.e1–6 (2014).

    Article  PubMed  Google Scholar 

  39. Furuya, H. et al. A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer’s disease with myoclonus and generalized convulsion. J. Neurol. Sci. 209, 75–77 (2003).

    Article  CAS  PubMed  Google Scholar 

  40. Ikeda, M. et al. The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients. Ann. Neurol. 40, 912–917 (1996).

    Article  CAS  PubMed  Google Scholar 

  41. Matsubara-Tsutsui, M. et al. Molecular evidence of presenilin 1 mutation in familial early onset dementia. Am. J. Med. Genet. 114, 292–298 (2002).

    Article  PubMed  Google Scholar 

  42. Kamimura K. et al. Familial Alzheimer’s disease genes in Japanese. J. Neurol. Sci. 160, 76–81 (1998).

    Article  CAS  PubMed  Google Scholar 

  43. Gomez-Isla, T. et al. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann. Neurol. 41, 809–813 (1997).

    Article  CAS  PubMed  Google Scholar 

  44. Larner, A. J., Ray, P. S. & Doran, M. The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer’s disease. J. Neurol. Sci. 252, 173–176 (2007).

    Article  CAS  PubMed  Google Scholar 

  45. Tanahashi, H. et al. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer’s disease patients. Neurosci. Lett. 218, 139–141 (1996).

    Article  CAS  PubMed  Google Scholar 

  46. Lendon, C. L. et al. E280A PS-1 mutation causes Alzheimer’s disease but age of onset is not modified by ApoE alleles. Hum. Mutation 10, 186–195 (1997).

    Article  CAS  Google Scholar 

  47. Shioi, J. et al. FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta. J. Neurochem. 101, 674–681 (2007).

    Article  CAS  PubMed  Google Scholar 

  48. Ch’ng, G. S., An, S. S., Bae, S. O., Bagyinszky, E. & Kim, S. Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family. Neuropsychiatr. Dis. Treat 11, 2315–23122 (2015).

    PubMed  PubMed Central  Google Scholar 

  49. Hamaguchi, T. et al. A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease. J. Neurology 256, 1575–1577 (2009).

    Article  Google Scholar 

  50. Tabira, T. et al. Alzheimer’s disease with spastic paresis and cotton wool type plaques. J. Neurosci. Res. 70, 367–372, (2002).

    Article  CAS  PubMed  Google Scholar 

  51. Aoki, M. et al. A presenilin-1 mutation in a Japanese family with Alzheimer’s disease and distinctive abnormalities on cranial MRI. Neurology 48,1118–1120 (1997).

    Article  CAS  PubMed  Google Scholar 

  52. Ikeuchi, T. et al. Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dement. Geriatr. Cogn. Disord. 26, 43–49 (2008).

    Article  CAS  PubMed  Google Scholar 

  53. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760 (1995).

    Article  CAS  PubMed  Google Scholar 

  54. Besançon, R. et al. Missense mutation in exon 11 (Codon 378) of the presenilin-1 gene in a French family with early-onset Alzheimer’s disease and transmission study by mismatch enhanced allele specific amplification. Hum. Mutat. 11, 481 (1998).

    Article  PubMed  Google Scholar 

  55. Finckh, U. et al. Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 6, 85–89 (2005).

    Article  CAS  PubMed  Google Scholar 

  56. Traykov, D. L. et al. Novel PSEN1 mutation in a Bulgarian patient with very early-onset Alzheimer’s disease, spastic paraparesis, and extrapyramidal signs. Am. J. Alzheimers Dis. Other Dement. 24, 404–407 (2009).

    Article  Google Scholar 

  57. Campion, D. et al. Mutations of the presenilin I gene in families with early-onset Alzheimer’s disease. Hum. Mol. Genet. 4, 2373–2377 (1995).

    Article  CAS  PubMed  Google Scholar 

  58. Yasuda, M. et al. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy. J. Neurol. Neurosurg. Psychiatry 68, 220–223 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Matsushita, S. et al. Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer’s disease. Biol. Psychiatry 52, 907–910 (2002).

    Article  CAS  PubMed  Google Scholar 

  60. Ishikawa, A. et al. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer’s disease. Ann. Neurology 57, 429–434 (2005).

    Article  CAS  Google Scholar 

  61. Tchernitchko, D., Goossens, M. & Wajcman, H. In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. Clin. Chem. 50, 1974–1978 (2004).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of BioNano Technology, Gachon University, Seoul, Korea

    Eva Bagyinszky, SunOh Bae & Seong Soo A. An

  2. Seoul National University, Bundang Hospital, Seoul, Korea

    SangYun Kim

Authors
  1. Eva Bagyinszky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. SunOh Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. SangYun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seong Soo A. An
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seong Soo A. An.

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bagyinszky, E., Bae, S., Kim, S. et al. In silico modeling of pathogenic point mutations in PSEN1 as studied in South-east Asia. Toxicol. Environ. Health Sci. 8, 135–153 (2016). https://doi.org/10.1007/s13530-016-0271-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13530-016-0271-3

Keywords

Search

Navigation